Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Bacterial Infections 1

Interventions

fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Surveys and Questionnaires 2Proton Therapy 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Music Therapy 2Mesna 2Melphalan 2Interviews as Topic 2Gene Expression Profiling 2Cyclophosphamide 2Busulfan 2tremelimumab 1motesanib diphosphate 1luprolide acetate gel depot 1liposomal amphotericin B 1durvalumab 1copanlisib 1chlorhexidine gluconate 1batifiban 1Whole Genome Sequencing 1Watchful Waiting 1Thrombopoietin 1Taxes 1Spermine Synthase 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasms × chlorhexidine gluconate × Clear all
NCT01817075 2021-06-22

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Children's Oncology Group

Phase 3 Completed
177 enrolled 15 charts
LymphoidOther hematologic neoplasm

Bacterial Infections, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡